Literature DB >> 30064550

Changes in Plasma Protein Expression Indicative of Early Diet-induced Metabolic Disease in Male Pigs (Sus scrofa).

Marinus Fw Te Pas1, Sietse-Jan Koopmans2, Leo Kruijt3, Sjef Boeren4, Mari A Smits3.   

Abstract

Recognition of the preclinical stages of metabolic diseases such as diabetes helps to prevent full development of the disease. In our research, we alter the diet composition of pigs to create a model of human metabolic disease. The objective of the current study was to identify plasma proteins and biologic mechanisms that differed in expression between pigs fed a 'cafeteria diet' (considered unhealthy; high in saturated fats) and those fed a 'Mediterranean diet' (considered healthy; high in unsaturated fats). Pigs fed the cafeteria diet showed increased plasma levels of proteins related to LDL ('bad cholesterol'), immune processes, blood clotting, and metal binding. The Mediterranean diet was associated with increased plasma quantities of proteins associated HDL particles ('good cholesterol'), binding of LDL particles, regulation of immune processes, and glycolysis. Pigs fed a cafeteria diet showed molecular signs of diabetes and atherosclerosis-even in the absence of clinical symptoms-which seemed to protect against the development of metabolic disorders. The current results suggest potential biomarkers of the early onset of metabolic syndromes. These biomarkers can help to reveal specific metabolic changes that precede the onset of diabetes, thus enabling the initiation of patient-specific interventions early during pathophysiologic development.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30064550      PMCID: PMC6103420          DOI: 10.30802/AALAS-CM-17-000099

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  46 in total

1.  Systems biology and new technologies enable predictive and preventative medicine.

Authors:  Leroy Hood; James R Heath; Michael E Phelps; Biaoyang Lin
Journal:  Science       Date:  2004-10-22       Impact factor: 47.728

2.  Free calcium in serum. II. Rigor of homeostatic control, correlations with total serum calcium, and review of data on patients with disturbed calcium metabolism.

Authors:  J H Ladenson; G N Bowers
Journal:  Clin Chem       Date:  1973-06       Impact factor: 8.327

Review 3.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

4.  Biomarkers as predictors of response to treatment with motesanib in patients with progressive advanced thyroid cancer.

Authors:  Michael B Bass; Steven I Sherman; Martin J Schlumberger; Martn J Schlumberger; Michael T Davis; Lisa Kivman; Huan-Mei Khoo; Kimberly H Notari; Matthew Peach; Yong-Jiang Hei; Scott D Patterson
Journal:  J Clin Endocrinol Metab       Date:  2010-08-25       Impact factor: 5.958

Review 5.  Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players.

Authors:  P Zimmet; E J Boyko; G R Collier; M de Courten
Journal:  Ann N Y Acad Sci       Date:  1999-11-18       Impact factor: 5.691

Review 6.  The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis.

Authors:  Anastassios G Pittas; Joseph Lau; Frank B Hu; Bess Dawson-Hughes
Journal:  J Clin Endocrinol Metab       Date:  2007-03-27       Impact factor: 5.958

Review 7.  Zinc and immune function: the biological basis of altered resistance to infection.

Authors:  A H Shankar; A S Prasad
Journal:  Am J Clin Nutr       Date:  1998-08       Impact factor: 7.045

8.  Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease.

Authors:  Koji Ohashi; Noriyuki Ouchi; Shinji Kihara; Tohru Funahashi; Tadashi Nakamura; Satoru Sumitsuji; Toshiharu Kawamoto; Satoru Matsumoto; Hiroyuki Nagaretani; Masahiro Kumada; Yoshihisa Okamoto; Hitoshi Nishizawa; Ken Kishida; Norikazu Maeda; Hisatoyo Hiraoka; Yoshio Iwashima; Kazuhiko Ishikawa; Mitsuru Ohishi; Tomohiro Katsuya; Hiromi Rakugi; Toshio Ogihara; Yuji Matsuzawa
Journal:  J Am Coll Cardiol       Date:  2004-04-07       Impact factor: 24.094

9.  Obesity and metabolic syndrome in circadian Clock mutant mice.

Authors:  Fred W Turek; Corinne Joshu; Akira Kohsaka; Emily Lin; Ganka Ivanova; Erin McDearmon; Aaron Laposky; Sue Losee-Olson; Amy Easton; Dalan R Jensen; Robert H Eckel; Joseph S Takahashi; Joseph Bass
Journal:  Science       Date:  2005-04-21       Impact factor: 47.728

10.  Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus.

Authors:  Ralph A Defronzo
Journal:  Diabetes       Date:  2009-04       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.